DRAM
Roundhill Memory ETF
stock BATS ETF

DRAM is a great add-on with SMH, especially as long as SK Hynix and Samsung don't have US listings. You get 98% of the memory industry with DRAM.

Get the DRAM ETF, better choice

There is a one day old fund that has some good companies.
Roundhill ETF Trust - Roundhill Memory ETF (DRAM).
It has Micron, Samsung, Sk hynix that make up 71%+ and Sandisk, Western Digital, and Seagate making up minority holdings, along with some lesser known names.
If you think memory will outperform semiconductors, it may be an good pick.
It does have only one day of history, so caveat emptor. It moved over 2.5M shares on its first day. It also has less than a million in assets.

I’ve held a bunch of the same positions you have (NVDA, PLTR, GOOGL, AMZN, etc). The question with individual stocks is that past performance ≠ future performance. Look at AMZN, for example—it barely moved in 2025. I recently sold it because, if an individual stock is going to underperform the benchmark, I may as well hold the benchmark. For me, I recently sold all of my individual stocks and went into 7 ETFs in 3 categories: (1) international (FNDF, AVDV), (2) US broad market (VTI, AVUS), and (3) growth (GRNY, GRNJ, DRAM). My growth category is my solution to “I want to get out of individual stock picking which takes up a ton of my headspace but I know it’s a stock picker’s market this year with the S&P overvalued, so I’ll outsource it based on my conviction on memory shortage + AI build out.” That’s not everyone’s philosophy, but I love how GRNY, GRNJ, and DRAM are ETFs with many companies I have held but not many companies in each. (I made a lot of money on Micron from Sept to February when I sold. I didn’t want to give up total exposure, though, so DRAM is great. Same with PLTR—bought it at $36, sold it at $181, but now I have it in GRNY vs individually.) I also love that GRNY and GRNJ are equal-weighted. Finally, I backtested using Claude my 7-ETF strategy against a 2 ETF strategy (VOO and VXUS) to see if my overcomplication was worth it. I had to use alternative ETFs for my growth ETFs since they’re so young, but my complicated portfolio far outperformed the 2 ETFs portfolio — not only in bull markets, not only over time, but even in 2022 bear market (it was down, but down less). That’s a very valuable exercise—though, for SMH (which I used as an alt for DRAM), I only permitted 50% of its returns since they’re so crazy from 2020-2025.

DRAM is a great add-on with SMH, especially as long as SK Hynix and Samsung don't have US listings. You get 98% of the memory industry with DRAM.

Get the DRAM ETF, better choice

There is a one day old fund that has some good companies.
Roundhill ETF Trust - Roundhill Memory ETF (DRAM).
It has Micron, Samsung, Sk hynix that make up 71%+ and Sandisk, Western Digital, and Seagate making up minority holdings, along with some lesser known names.
If you think memory will outperform semiconductors, it may be an good pick.
It does have only one day of history, so caveat emptor. It moved over 2.5M shares on its first day. It also has less than a million in assets.

I’ve held a bunch of the same positions you have (NVDA, PLTR, GOOGL, AMZN, etc). The question with individual stocks is that past performance ≠ future performance. Look at AMZN, for example—it barely moved in 2025. I recently sold it because, if an individual stock is going to underperform the benchmark, I may as well hold the benchmark. For me, I recently sold all of my individual stocks and went into 7 ETFs in 3 categories: (1) international (FNDF, AVDV), (2) US broad market (VTI, AVUS), and (3) growth (GRNY, GRNJ, DRAM). My growth category is my solution to “I want to get out of individual stock picking which takes up a ton of my headspace but I know it’s a stock picker’s market this year with the S&P overvalued, so I’ll outsource it based on my conviction on memory shortage + AI build out.” That’s not everyone’s philosophy, but I love how GRNY, GRNJ, and DRAM are ETFs with many companies I have held but not many companies in each. (I made a lot of money on Micron from Sept to February when I sold. I didn’t want to give up total exposure, though, so DRAM is great. Same with PLTR—bought it at $36, sold it at $181, but now I have it in GRNY vs individually.) I also love that GRNY and GRNJ are equal-weighted. Finally, I backtested using Claude my 7-ETF strategy against a 2 ETF strategy (VOO and VXUS) to see if my overcomplication was worth it. I had to use alternative ETFs for my growth ETFs since they’re so young, but my complicated portfolio far outperformed the 2 ETFs portfolio — not only in bull markets, not only over time, but even in 2022 bear market (it was down, but down less). That’s a very valuable exercise—though, for SMH (which I used as an alt for DRAM), I only permitted 50% of its returns since they’re so crazy from 2020-2025.

Unpopular opinion. :) SMH holds AI 1.0 winners, the build out. The next phase is memory (DRAM) and data centers (GRNY).

Lam Research is one of the most important companies in semiconductor manufacturing and the market keeps treating it like a commodity cycle name you buy and sell with wafer shipments.
The buyback story alone deserves more attention. The board has authorized over $5.1B in repurchases and Lam has been consistent about executing it. At a company doing roughly $4-5B in free cash flow annually at cycle peaks, that is a serious commitment to returning capital. They also raised the dividend meaningfully over the past two years. When a company in a capital-intensive, cyclical industry chooses to buy back this aggressively, it usually means management thinks the stock is cheap relative to normalized earnings. I tend to agree.
The bear case everyone knows: China exposure, export restrictions, WFE spending cycles. Those are real. But the structural story is more interesting. Lam's etch and deposition equipment is not easily substituted. When fabs are building out NAND, DRAM, and advanced logic, Lam is getting called first. The installed base is enormous and the aftermarket parts and service revenue is growing steadily. That recurring piece of the business is starting to matter more and it barely gets priced into the model.
The chip cycle is going to turn. It always does. And when it does, Lam comes into that recovery with a leaner cost structure, a lower share count, and a higher dividend. The stock does not need a heroic recovery to work — it just needs normal capital allocation math to catch up.
Right now the multiple reflects the cyclical trough narrative more than the earnings power at a mid-cycle. On normalized FCF, you are not paying a crazy price for one of three or four companies that essentially control how the world makes chips. That setup is more interesting than the market is giving it credit for.

Apple Is Reportedly Buying Up “All Available” Mobile DRAM At Very High Prices To Starve Out Its Competitors